Enteral L-Arginine and Glutamine Supplementation for Prevention of NEC in Preterm Neonates

Objective. Evaluating the efficacy and safety of arginine and glutamine supplementation in decreasing the incidence of NEC among preterm neonates. Methods. Prospective case-control study done on 75 preterm neonates ≤34 weeks, divided equally into L-arginine group receiving enteral L-arginine, glutam...

Full description

Saved in:
Bibliographic Details
Main Authors: M. S. El-Shimi, H. A. Awad, M. A. Abdelwahed, M. H. Mohamed, S. M. Khafagy, G. Saleh
Format: Article
Language:English
Published: Wiley 2015-01-01
Series:International Journal of Pediatrics
Online Access:http://dx.doi.org/10.1155/2015/856091
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832552177997971456
author M. S. El-Shimi
H. A. Awad
M. A. Abdelwahed
M. H. Mohamed
S. M. Khafagy
G. Saleh
author_facet M. S. El-Shimi
H. A. Awad
M. A. Abdelwahed
M. H. Mohamed
S. M. Khafagy
G. Saleh
author_sort M. S. El-Shimi
collection DOAJ
description Objective. Evaluating the efficacy and safety of arginine and glutamine supplementation in decreasing the incidence of NEC among preterm neonates. Methods. Prospective case-control study done on 75 preterm neonates ≤34 weeks, divided equally into L-arginine group receiving enteral L-arginine, glutamine group receiving enteral glutamine, and control group. Serum L-arginine and glutamine levels were measured at time of enrollment (sample 1), after 14 days of enrollment (sample 2), and at time of diagnosis of NEC (sample 3). Results. The incidence of NEC was 9.3%. There was no difference in the frequency of NEC between L-arginine and control groups (P>0.05). NEC was not detected in glutamine group; L-arginine concentrations were significantly lower in arginine group than control group in both samples while glutamine concentrations were comparable in glutamine and control groups in both samples. No significant difference was found between groups as regards number of septic episodes, duration to reach full oral intake, or duration of hospital stay. Conclusion. Enteral L-arginine supplementation did not seem to reduce the incidence of NEC. Enteral glutamine may have a preventive role against NEC if supplied early to preterm neonates. However, larger studies are needed to confirm these findings. This work is registered in ClinicalTrials.gov (ClinicalTrials.gov Identifier: NCT01263041).
format Article
id doaj-art-b6845ec5d3aa4617b141a35f3e7aa0f0
institution Kabale University
issn 1687-9740
1687-9759
language English
publishDate 2015-01-01
publisher Wiley
record_format Article
series International Journal of Pediatrics
spelling doaj-art-b6845ec5d3aa4617b141a35f3e7aa0f02025-02-03T05:59:25ZengWileyInternational Journal of Pediatrics1687-97401687-97592015-01-01201510.1155/2015/856091856091Enteral L-Arginine and Glutamine Supplementation for Prevention of NEC in Preterm NeonatesM. S. El-Shimi0H. A. Awad1M. A. Abdelwahed2M. H. Mohamed3S. M. Khafagy4G. Saleh5Pediatric Department, Faculty of Medicine, Ain Shams University, Cairo 16088, EgyptPediatric Department, Faculty of Medicine, Ain Shams University, Cairo 16088, EgyptPediatric Department, Faculty of Medicine, Ain Shams University, Cairo 16088, EgyptPediatric Department, Faculty of Medicine, Ain Shams University, Cairo 16088, EgyptPediatric Department, Faculty of Medicine, Ain Shams University, Cairo 16088, EgyptPediatric Department, Faculty of Medicine, Ain Shams University, Cairo 16088, EgyptObjective. Evaluating the efficacy and safety of arginine and glutamine supplementation in decreasing the incidence of NEC among preterm neonates. Methods. Prospective case-control study done on 75 preterm neonates ≤34 weeks, divided equally into L-arginine group receiving enteral L-arginine, glutamine group receiving enteral glutamine, and control group. Serum L-arginine and glutamine levels were measured at time of enrollment (sample 1), after 14 days of enrollment (sample 2), and at time of diagnosis of NEC (sample 3). Results. The incidence of NEC was 9.3%. There was no difference in the frequency of NEC between L-arginine and control groups (P>0.05). NEC was not detected in glutamine group; L-arginine concentrations were significantly lower in arginine group than control group in both samples while glutamine concentrations were comparable in glutamine and control groups in both samples. No significant difference was found between groups as regards number of septic episodes, duration to reach full oral intake, or duration of hospital stay. Conclusion. Enteral L-arginine supplementation did not seem to reduce the incidence of NEC. Enteral glutamine may have a preventive role against NEC if supplied early to preterm neonates. However, larger studies are needed to confirm these findings. This work is registered in ClinicalTrials.gov (ClinicalTrials.gov Identifier: NCT01263041).http://dx.doi.org/10.1155/2015/856091
spellingShingle M. S. El-Shimi
H. A. Awad
M. A. Abdelwahed
M. H. Mohamed
S. M. Khafagy
G. Saleh
Enteral L-Arginine and Glutamine Supplementation for Prevention of NEC in Preterm Neonates
International Journal of Pediatrics
title Enteral L-Arginine and Glutamine Supplementation for Prevention of NEC in Preterm Neonates
title_full Enteral L-Arginine and Glutamine Supplementation for Prevention of NEC in Preterm Neonates
title_fullStr Enteral L-Arginine and Glutamine Supplementation for Prevention of NEC in Preterm Neonates
title_full_unstemmed Enteral L-Arginine and Glutamine Supplementation for Prevention of NEC in Preterm Neonates
title_short Enteral L-Arginine and Glutamine Supplementation for Prevention of NEC in Preterm Neonates
title_sort enteral l arginine and glutamine supplementation for prevention of nec in preterm neonates
url http://dx.doi.org/10.1155/2015/856091
work_keys_str_mv AT mselshimi enterallarginineandglutaminesupplementationforpreventionofnecinpretermneonates
AT haawad enterallarginineandglutaminesupplementationforpreventionofnecinpretermneonates
AT maabdelwahed enterallarginineandglutaminesupplementationforpreventionofnecinpretermneonates
AT mhmohamed enterallarginineandglutaminesupplementationforpreventionofnecinpretermneonates
AT smkhafagy enterallarginineandglutaminesupplementationforpreventionofnecinpretermneonates
AT gsaleh enterallarginineandglutaminesupplementationforpreventionofnecinpretermneonates